In secondary analysis of the MOZART trial, FRS and CAC score improved in a greater proportion of patients with ezetimibe but did not reach statistical significance[ 29 ].
1
—
—
In secondary analysis of the MOZART trial, FRS and CAC score improved in a greater proportion of patients with ezetimibe but did not reach statistical significance[ 29 ].